FDA Drugs recall ·

Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton… recall

Recall number
D-0224-2025
Date
(initiated January 21, 2025)
Company / brand
AvKARE
615 N 1st St, Pulaski, TN, United States
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
341 cartons
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15

Why was it recalled?

Out of Specification for Dissolution

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot 45279, Exp 03/31/2025

Distribution

Nationwide in the USA

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0224-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.